Quest Diagnostics Incorporated is an American clinical laboratory. A Fortune 500 company, Quest operates in the United States, Puerto Rico, Mexico, and Brazil.[3] Quest also maintains collaborative agreements with various hospitals and clinics across the globe.[4]
![]() | |
Company type | Public |
---|---|
Industry | Health care |
Founded | 1967New York City, New York, U.S. | in
Founder | Paul Brown |
Headquarters | Secaucus, New Jersey, U.S. |
Area served | |
Key people | Jim Davis (CEO)[1] |
Services | |
Revenue | ![]() |
![]() | |
![]() | |
Total assets | ![]() |
Total equity | ![]() |
Number of employees | 48,000 (2023) |
Website | questdiagnostics |
Footnotes / references [2] |
As of 2020, the company had approximately 48,000 employees, and it generated more than $7.7 billion in revenue in 2019.[5][6] The company offers access to diagnostic testing services for cancer, cardiovascular disease, infectious disease, neurological disorders, COVID-19, and employment and court-ordered drug testing.[7]
History
![](http://upload.wikimedia.org/wikipedia/commons/thumb/a/a0/Counter_space_at_Quest_Diagnostics_in_Franconia.jpg/220px-Counter_space_at_Quest_Diagnostics_in_Franconia.jpg)
1960–1995
Originally founded as Metropolitan Pathology Laboratory, Inc. in 1967 by Paul A. Brown, MD, the clinical laboratory underwent a variety of name changes.[8] In 1969, the company's name changed to MetPath, Inc.[9] with headquarters in Teaneck, New Jersey. By 1982, MetPath was acquired by what was then known as Corning Glass Works[10] and was subsequently renamed Corning Clinical Laboratories.[11]
1996–2000
On December 31, 1996, Quest Diagnostics became an independent company as a spin-off from Corning.[11][12] Kenneth W. Freeman was appointed as CEO during this transition.[13][14] Over the next year, Quest acquired a clinical laboratory division of Branford, CT–based Diagnostic Medical Laboratory, Inc. (DML).[15] Two years later in 1999, Quest added SmithKline Beecham Clinical Laboratories to their subsidiaries;[16][17] which includes a joint venture ownership with CompuNet Clinical Laboratory.[18] The purchase of SmithKline Beecham also included the lab's medical sample transport airline (ICAO: LBQ, call sign: LABQUEST) originally founded in 1988.[19]
In 1997, Quest and Banner Health formed a joint venture creating the Arizona based Sonora Quest laboratory, a business unit of Laboratory Sciences of Arizona.[20] This entity represents the operations of Quest Diagnostics in the Arizona regional market.
2001–2015
![](http://upload.wikimedia.org/wikipedia/commons/thumb/3/3f/Steve_Rusckowski_at_the_World_Economic_Forum.jpg/220px-Steve_Rusckowski_at_the_World_Economic_Forum.jpg)
From May 2004 to April 2012, Surya Mohapatra served as the company's President and CEO. In 2007 Quest acquired diagnostic testing equipment company AmeriPath.[21] In response to Mohapatra's resignation after eight years with Quest, former Philips Healthcare CEO Stephen Rusckowski was appointed.[22] Under Rusckowski, Quest Diagnostics teamed up with central New England's largest health care system, UMass Memorial Health Care, to purchase its clinical outreach laboratory.[23]
2016–present
In 2016, Quest collaborated with Safeway to bring testing services to twelve of its stores in California, Maryland, Virginia, Texas and Colorado.[24]
By the end of 2017, Quest, in partnership with Walmart, incorporated laboratory testing in about 15 of their locations in Texas and Florida.[25]
In May 2018, the company announced it will become an in-network laboratory provider to UnitedHealthcare starting in 2019, providing access to 48 million plan members.[26]
In September 2018, Quest moved its headquarters from Madison, where it was located since 2007, to Secaucus, New Jersey.[27][28]
In November 2018, Quest launched QuestDirect, a consumer-initiated testing service that allows patients to order health and wellness lab testing from home.[29][30]
In March 2020, the company launched a COVID-19 testing service.[31] As of July 2020, Quest had performed more than 9.2 million COVID-19 molecular tests and 2.8 million serology tests.[32]
In April 2024, Quest has added a new blood screening to their AD-Detect product line. This test will analyze the blood for a specific Alzheimer's protein, pTau-217.[33]
Acquisitions
Date | Company | Business | Location | Value (USD) | References |
---|---|---|---|---|---|
1999 | SmithKline Beecham Clinical Laboratories | Laboratory | USA | 1.3×10 9 | [34] |
2001 | MedPlus, Inc. (Nasdaq: MEDP) | healthcare technology company | Ohio | ||
2002 | American Medical Laboratories, Inc. (AML) & LabPortal, Inc. | healthcare technology company | Virginia | 500,000,000 | |
2003 | Unilab Corporation (Nasdaq: ULAB) | healthcare technology company | California | 800,000,000 | |
2005 | LabOne, Inc. (Nasdaq: LABS) | Employer drug testing and paramedical testing division | Lenexa, Kansas | 934,000,000 | |
2006 | Focus Diagnostics, Inc. | Infectious and immunologic disease laboratory | Virginia | 185,000,000 | |
2007 | Hemocue | point-of-care diagnostic testing | Sweden | ||
2007 | AmeriPath (and subsidiary Specialty Laboratories) | cancer diagnostic testing | |||
2011 | Athena Diagnostics | cancer diagnostic testing | [35] | ||
2011 | Celera Corporation | NGS | [36] | ||
2013 | Outreach for UMass Memorial Health | Laboratory | Massachusetts | [37] | |
2014 | Solstas Lab Partners Group | Laboratory | 570,000,000 | [38] | |
2014 | Summit Health, Inc. | [39] | |||
2015 | Barnabas Health | Laboratory operations | New Jersey | [40] | |
2017 | Cleveland HeartLab | Laboratory | [41] | ||
2018 | Oxford Immunotec. | Laboratory | [42] | ||
2019 | Boyce & Bynum Pathology Laboratories | Laboratory | [43] | ||
2020 | Outreach for Memorial Hermann Health System | Outreach Laboratory | Houston | [44] | |
2020 | Hackensack Meridian Health | Laboratory operations | New Jersey | [45] | |
2021 | Outreach for Mercy | Outreach Laboratory | USA | [46] | |
2023 | Outreach for NewYork-Presbyterian Hospital | Outreach Laboratory | New York | [47] | |
2024 | Outreach for Steward Health Care System | Outreach Laboratory | USA | [48] | |
2024 | Lenco Diagnostic Laboratories | Laboratory | Brooklyn, New York | [49] |
Partnerships
- 2005: Forms a strategic alliance with Ciphergen Biosystems to commercialize novel proteomic tests.[50]
Controversies
Quest Diagnostics set a record in April 2009 when it paid $302 million to the government to settle a Medicare fraud case alleging the company sold faulty medical testing kits. It was the largest qui tam (whistleblower) settlement paid by a medical lab for manufacturing and distributing a faulty product.[51] In May 2011, Quest paid $241 million to the state of California to settle a False Claims Act case that alleged the company had overcharged Medi-Cal, the state's Medicaid program, and provided illegal kickbacks as incentives for healthcare providers to use Quest labs.[52]
In 2018, Quest Diagnostics was among a number of US based labs linked to inaccuracies of over 200 women's cervical smear tests for CervicalCheck, Ireland's national screening program.[53][54] Audits of the testing performed by Quest (and another subcontractor Clinical Pathology Laboratories, Inc. of Austin Texas) showed a high rate of errors in analysis of samples which led to lawsuits[55] and a government inquiry. Quest and the Irish government continue to settle the resulting lawsuits.[56][57]
On June 3, 2019, Quest announced that American Medical Collection Agency (AMCA), a billing collections service provider, had informed Quest Diagnostics that an unauthorized user had access to AMCA’s system containing personal information AMCA received from various entities, including from Quest.[58] AMCA provides billing collections services to Optum360, which in turn is a Quest contractor.[59] AMCA later went bankrupt after the breach.[60]
References
External links
- Official website
- Business data for Quest Diagnostics Incorporated: